Steven Caras

Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial

David C. Whitcomb, Glen A. Lehman, G. A. VASIL'EVA et al. · The American Journal of Gastroenterology · 2010 · 190 citations

Medicine, Clinical Pharmacy, Pharmacotherapy +17

A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery

Ewa Małecka‐Panas, Glen A. Lehman, G. A. VASIL'EVA et al. · Alimentary Pharmacology & Therapeutics · 2011 · 105 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety

Daniel E. Falk, Megan L. Ryan, Joanne B. Fertig et al. · Alcoholism Clinical and Experimental Research · 2018 · 85 citations

Medicine, Pharmacology, Psychiatry +14

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

Bruce C. Trapnell, Karen Maguiness, Gavin R. Graff et al. · Journal of Cystic Fibrosis · 2009 · 72 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects

Steven Caras, İrfan Soykan, V. Beverly et al. · Neurogastroenterology & Motility · 1997 · 38 citations

Medicine, Pharmacology, Physiology +14